US$ 27.26
astrazeneca glp 1 drug GLP-1 pill shows promise in obesity, diabetes trials AstraZeneca’s experimental obesity pill helped
Description
doi: 10.1007/s00125-023-06053-9, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 98
it's about increasing treatment options and personalizing it to each patient's preferences and needs

35 , e3070

Zheng, Z
)
Healthcare providers also gain new opportunities to personalize treatment

Research indicates that GLP-1RAs can provide additional therapeutic support for autoimmune skin conditions, including Pso and HS, through immune response regulation [61]